Simvastatin solid lipid nanoparticles for oral delivery: Formulation development and in vivo evaluation

Indian Journal of Pharmaceutical Sciences

Volumn 75, Issue 5, 2013, Pages 591-598

  Padhye, S G ^a   Nagarsenker, Mangal S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Hyperlipidemia; Simvastatin; Solid lipid nanoparticles

Indexed keywords

CHOLESTEROL; GELUCIRE; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NANOCARRIER; POLYSORBATE 80; SIMVASTATIN; SOLID LIPID NANOPARTICLE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CRYSTALLIZATION; DESICCATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; DRUG SCREENING; DRUG STABILITY; ELECTRON MICROSCOPY; EMULSION; EVAPORATION; FEMALE; FLOW KINETICS; HYPERLIPIDEMIA; IN VIVO STUDY; MELTING POINT; NANOEMULSION; NONHUMAN; PARTICLE SIZE; POWDER; RAT; SPRAY DRYING; THERMAL ANALYSIS; X RAY DIFFRACTION;

EID: 84890456352     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201-30.
2. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993;82:979-87.
3. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77.
4. Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 2006;112:71-105.
5. Patel K, Padhye S, Nagarsenker M. Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design. AAPS PharmSciTech 2012;13:125-33.
6. Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 2007;8:162-70.
7. Vivek K, Reddy H, Murthy RS. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007;8:16-24.
8. Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 2011;415:232-43.
9. Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm 2010;394:147-53.
10. Nagarsenker MS, Date AA. Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. J Pharm Pharmacol 2007;59:1583-4.
11. Dixit RP, Barhate CR, Padhye SG, Viswanathan CL, Nagarsenker MS. Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from Tablet dosage form. Indian J Pharm Sci 2010;72:204-10.
12. Freitas C, Müller RH. Spray-drying of solid lipid nanoparticles (SLNTM). Eur J Pharm Biopharm 1998;46:145-51.
13. Westesen K, Bunjes H, Koch MH. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 1997;48:223-36.
14. Schwarz C. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J Microencapsul 1999;16:205-13.
15. Han F, Li S, Yin R, Liu H, Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf Physicochem Eng Aspects 2008;315:210-6.
16. Cavalli R, Gasco MR, Barresi AA, Rovero G. Evaporative drying of aqueous dispersions of solid lipid nanoparticles. Drug Dev Ind Pharm 2001;27:919-24.
17. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.